Literature DB >> 18091000

Adjustment for multiple cardiovascular risk factors using a summary risk score.

Patrick G Arbogast1, Lisa Kaltenbach, Hua Ding, Wayne A Ray.   

Abstract

BACKGROUND: To simultaneously adjust for confounding by multiple cardiovascular risk factors, recently published pharmacoepidemiologic studies have used an index of risk of cardiovascular disease (a cardiovascular risk score). This summary measure is a multivariate confounder score created from regression models relating these risk factors to the outcome. The score is then used in regression models to adjust for potential confounding of the exposure of interest. Although this summary score has a number of advantages, there is concern that it may result in underestimation of the standard error of the exposure estimate and thus inflate the number of statistically significant results.
METHODS: We conducted simulation studies comparing regression models adjusting for all risk factors directly to models using this summary risk score for large cohort studies.
RESULTS: Results indicated that, as long as there was not a high degree of intercorrelation between the potential confounders and the exposure, estimated standard errors from the regression models using this summary risk score approximate their empirical standard errors well and are similar to the standard errors from the regression models directly adjusting for all risk factors.
CONCLUSIONS: Based on these simulation results, using this summary risk score can be a reasonable approach for summarizing many risk factors in large cohort studies.

Entities:  

Mesh:

Year:  2008        PMID: 18091000     DOI: 10.1097/EDE.0b013e31815be000

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  24 in total

1.  Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding.

Authors:  Wayne A Ray; Cecilia P Chung; Katherine T Murray; Walter E Smalley; James R Daugherty; William D Dupont; C Michael Stein
Journal:  JAMA       Date:  2018-12-04       Impact factor: 56.272

2.  Azithromycin and the risk of cardiovascular death.

Authors:  Wayne A Ray; Katherine T Murray; Kathi Hall; Patrick G Arbogast; C Michael Stein
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

3.  Masked Hypertension and Cardiovascular Disease Events in a Prospective Cohort of Blacks: The Jackson Heart Study.

Authors:  John N Booth; Keith M Diaz; Samantha R Seals; Mario Sims; Joseph Ravenell; Paul Muntner; Daichi Shimbo
Journal:  Hypertension       Date:  2016-06-27       Impact factor: 10.190

4.  Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone.

Authors:  Tony Antoniou; Simon Hollands; Erin M Macdonald; Tara Gomes; Muhammad M Mamdani; David N Juurlink
Journal:  CMAJ       Date:  2015-02-02       Impact factor: 8.262

5.  Development of a cardiovascular risk score for use in low- and middle-income countries.

Authors:  Stella Aslibekyan; Hannia Campos; Eric B Loucks; Crystal D Linkletter; Jose M Ordovas; Ana Baylin
Journal:  J Nutr       Date:  2011-05-11       Impact factor: 4.798

6.  Evaluating Community-Based Translational Interventions Using Historical Controls: Propensity Score vs. Disease Risk Score Approach.

Authors:  Luohua Jiang; Shuai Chen; Janette Beals; Juned Siddique; Richard F Hamman; Ann Bullock; Spero M Manson
Journal:  Prev Sci       Date:  2019-05

7.  High-Dose Citalopram and Escitalopram and the Risk of Out-of-Hospital Death.

Authors:  Wayne A Ray; Cecilia P Chung; Katherine T Murray; Kathi Hall; C Michael Stein
Journal:  J Clin Psychiatry       Date:  2017-02       Impact factor: 4.384

8.  Evaluation of propensity scores, disease risk scores, and regression in confounder adjustment for the safety of emerging treatment with group sequential monitoring.

Authors:  Stanley Xu; Susan Shetterly; Andrea J Cook; Marsha A Raebel; Sunali Goonesekera; Azadeh Shoaibi; Jason Roy; Bruce Fireman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-02-15       Impact factor: 2.890

9.  Depressive Symptoms and Risk of Cardiovascular Events in Blacks: Findings From the Jackson Heart Study.

Authors:  Emily C O'Brien; Melissa A Greiner; Mario Sims; Natalie Chantelle Hardy; Wei Wang; Eyal Shahar; Adrian F Hernandez; Lesley H Curtis
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-11-17

10.  Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.

Authors:  Laura Y Park-Wyllie; Muhammad M Mamdani; Ping Li; Sudeep S Gill; Andreas Laupacis; David N Juurlink
Journal:  PLoS Med       Date:  2009-09-29       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.